Reviva Pharmaceuticals Holdings, Inc.
RVPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$29,919 | -$39,261 | -$24,339 | -$8,522 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,630 | $3,413 | $177 | $107 |
| Change in WC | -$4,538 | $7,284 | $8,929 | -$702 |
| Other Non-Cash | -$718 | $239 | -$3,727 | -$1,551 |
| Operating Cash Flow | -$33,544 | -$28,324 | -$18,961 | -$10,668 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $458 | $0 | $0 | $0 |
| Stock Issued | $23,194 | $27,494 | $7,774 | $31,497 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $5,678 | $19 | $98 |
| Financing Cash Flow | $23,653 | $33,172 | $7,792 | $31,596 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$9,891 | $4,848 | -$11,168 | $20,927 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $23,367 | $18,520 | $29,688 | $8,760 |
| End Cash | $13,476 | $23,367 | $18,520 | $29,688 |
| Free Cash Flow | -$33,544 | -$28,324 | -$18,961 | -$10,668 |